title: Intravenous versus subcutaneous EPO: anything to do with pure red cell aplasia complication.
authors.forename: Kai Ming
authors.initials: KM
authors.lastname: Chow
authors.forename: Cheuk Chun
authors.initials: CC
authors.lastname: Szeto
authors.forename: Philip Kam-Tao
authors.initials: PK
authors.lastname: Li
mesh_terms: D004921:Erythropoietin / Q000008:administration & dosage*; D006801:Humans; D007275:Injections, Intravenous / Q000009:adverse effects / Q000379:methods; D007279:Injections, Subcutaneous / Q000009:adverse effects / Q000379:methods; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000209:etiology*
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin